272, Novartis Investigational Site — Charleston, South Carolina

272, Novartis Investigational Site is a clinical research site located in Charleston, South Carolina, United States 29407.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

272, Novartis Investigational Site has participated in 1 clinical trials.

Therapeutic areas: Influenza Virus.

Sponsors: Seqirus.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 272, Novartis Investigational Site?

272, Novartis Investigational Site has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 272, Novartis Investigational Site conducted?

272, Novartis Investigational Site has 1 clinical trials on record. Their work covers Influenza Virus.

Is 272, Novartis Investigational Site accredited by Crixeo Health?

272, Novartis Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 272, Novartis Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.